News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trial and Errors: Pfizer Inc. (PFE)'s Drug Failures Are the Result of Bad Management, Not Clinical Misfortune



6/25/2010 8:42:39 AM

The FDA’s decision to nix Pfizer (PFE)’s development of a new osteoarthritis drug, tanezumab, reveals some serious errors of judgment among management. Especially when you couple it with the company’s confession that it will not proceed with a study of the antipsychotic Geodon in children in part because it cannot meet an FDA deadline.

Read at BNET


comments powered by Disqus
BNET
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES